• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[皮肌炎和抗合成酶综合征的早期症状]

[Early symptoms of dermatomyositis and antisynthetase syndrome].

作者信息

Maurer B

机构信息

Klinik für Rheumatologie, Universitätsspital Zürich, Gloriastr. 25, 8091, Zürich, Schweiz,

出版信息

Z Rheumatol. 2013 Dec;72(10):970-6. doi: 10.1007/s00393-013-1196-8.

DOI:10.1007/s00393-013-1196-8
PMID:24337199
Abstract

INTRODUCTION

The early diagnosis of rheumatic diseases is becoming increasingly important. This particularly includes inflammatory myopathies which are multisystemic disorders with visceral involvement that are associated with high morbidity and mortality. Early diagnosis before the development of irreversible organ involvement is, therefore, of great importance.

METHODS

This report provides information on early signs and symptoms of dermatomyositis and antisynthetase syndrome. Furthermore, screening methods which allow early diagnosis including involvement of internal organs are discussed. In addition, clinical and serological subtypes and their impact on prognosis are described.

摘要

引言

风湿性疾病的早期诊断变得越来越重要。这尤其包括炎性肌病,它们是伴有内脏受累的多系统疾病,与高发病率和死亡率相关。因此,在不可逆器官受累发生之前进行早期诊断非常重要。

方法

本报告提供了关于皮肌炎和抗合成酶综合征早期体征和症状的信息。此外,还讨论了能够实现早期诊断(包括内脏受累情况)的筛查方法。此外,还描述了临床和血清学亚型及其对预后的影响。

相似文献

1
[Early symptoms of dermatomyositis and antisynthetase syndrome].[皮肌炎和抗合成酶综合征的早期症状]
Z Rheumatol. 2013 Dec;72(10):970-6. doi: 10.1007/s00393-013-1196-8.
2
[Idiopathic Inflammatory Myopathies].[特发性炎性肌病]
Dtsch Med Wochenschr. 2020 Jul;145(13):903-910. doi: 10.1055/a-1018-3008. Epub 2020 Jul 2.
3
Classification of idiopathic inflammatory myopathies: pathology perspectives.特发性炎性肌病的分类:病理学视角。
Curr Opin Neurol. 2019 Oct;32(5):704-714. doi: 10.1097/WCO.0000000000000740.
4
239th ENMC International Workshop: Classification of dermatomyositis, Amsterdam, the Netherlands, 14-16 December 2018.第239届ENMC国际研讨会:皮肌炎的分类,荷兰阿姆斯特丹,2018年12月14日至16日。
Neuromuscul Disord. 2020 Jan;30(1):70-92. doi: 10.1016/j.nmd.2019.10.005. Epub 2019 Oct 25.
5
Where are we moving in the classification of idiopathic inflammatory myopathies?特发性炎性肌病的分类我们将如何进展?
Curr Opin Neurol. 2020 Oct;33(5):590-603. doi: 10.1097/WCO.0000000000000855.
6
[Inflammatory myopathies].[炎性肌病]
Riv Neurol. 1988 Jan-Feb;58(1):11-4.
7
[Skin Manifestations in Dermatomyositis and Antisynthetase Syndrome].[皮肌炎和抗合成酶综合征中的皮肤表现]
Brain Nerve. 2021 Feb;73(2):137-146. doi: 10.11477/mf.1416201726.
8
Classification, diagnosis, and management of idiopathic inflammatory myopathies.特发性炎性肌病的分类、诊断和治疗。
J Rheumatol. 2013 May;40(5):550-64. doi: 10.3899/jrheum.120682. Epub 2013 Mar 15.
9
Antisynthetase syndrome: a different diagnosis to dermatomyositis.抗合成酶综合征:一种与皮肌炎不同的诊断。
Acta Derm Venereol. 2013 Jul 6;93(4):477-8. doi: 10.2340/00015555-1503.
10
Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies.基于临床表现和肌炎特异性自身抗体的特发性炎性肌病新分类系统的建立。
JAMA Neurol. 2018 Dec 1;75(12):1528-1537. doi: 10.1001/jamaneurol.2018.2598.

引用本文的文献

1
Characterisation of Disease Patterns of Dermatomyositis with Different Initial Manifestations.不同初始表现的皮肌炎疾病模式特征
Int J Gen Med. 2022 Aug 9;15:6519-6528. doi: 10.2147/IJGM.S372658. eCollection 2022.
2
[Raynaud's phenomenon : Practical management].[雷诺现象:实际管理]
Z Rheumatol. 2019 Dec;78(10):967-978. doi: 10.1007/s00393-019-00723-z.

本文引用的文献

1
Autoantibodies in polymyositis and dermatomyositis.多发性肌炎和皮肌炎中的自身抗体。
Curr Rheumatol Rep. 2013 Jun;15(6):335. doi: 10.1007/s11926-013-0335-1.
2
Electrodiagnostic evaluation of myopathies.肌病的电诊断评估
Phys Med Rehabil Clin N Am. 2013 Feb;24(1):193-207. doi: 10.1016/j.pmr.2012.08.017. Epub 2012 Oct 16.
3
Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), physician global damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index-2 (FI-2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI).
成人及青少年皮肌炎、多发性肌炎和包涵体肌炎的评估指标:医生及患者/家长整体活动度、徒手肌力测试(MMT)、健康评估问卷(HAQ)/儿童健康评估问卷(C-HAQ)、儿童肌炎评估量表(CMAS)、肌炎疾病活动评估工具(MDAAT)、疾病活动评分(DAS)、简明健康状况调查问卷(SF-36)、儿童健康问卷(CHQ)、医生整体损伤程度、肌炎损伤指数(MDI)、定量肌肉测试(QMT)、肌炎功能指数-2(FI-2)、肌炎活动概况(MAP)、包涵体肌炎功能评定量表(IBMFRS)、皮肤型皮肌炎疾病面积和严重程度指数(CDASI)、皮肤评估工具(CAT)、皮肌炎皮肤严重程度指数(DSSI)、皮肤指数及皮肤病生活质量指数(DLQI)。
Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11(0 11):S118-57. doi: 10.1002/acr.20532.
4
Morbidity and mortality in adult polymyositis and dermatomyositis.成人多发性肌炎和皮肌炎的发病率和死亡率。
Curr Rheumatol Rep. 2012 Jun;14(3):275-85. doi: 10.1007/s11926-012-0249-3.
5
Screening for interstitial lung disease in systemic sclerosis: the diagnostic accuracy of HRCT image series with high increment and reduced number of slices.系统性硬化症中肺间质疾病的筛查:高增量和减少切片数量的 HRCT 图像系列的诊断准确性。
Ann Rheum Dis. 2012 Apr;71(4):549-52. doi: 10.1136/annrheumdis-2011-200564. Epub 2011 Nov 25.
6
KL-6: a serological biomarker for interstitial lung disease in patients with polymyositis and dermatomyositis.KL-6:多发性肌炎和皮肌炎患者间质性肺病的血清学标志物。
J Intern Med. 2012 Jun;271(6):589-97. doi: 10.1111/j.1365-2796.2011.02459.x. Epub 2011 Oct 31.
7
Pathogenesis and therapies of immune-mediated myopathies.免疫介导性肌病的发病机制和治疗方法。
Autoimmun Rev. 2012 Jan;11(3):203-6. doi: 10.1016/j.autrev.2011.05.013. Epub 2011 May 18.
8
Antisynthetase syndrome.抗合成酶综合征。
Curr Rheumatol Rep. 2011 Jun;13(3):175-81. doi: 10.1007/s11926-011-0176-8.
9
Interleukin-17 and interleukin-23 in patients with polymyositis and dermatomyositis.白细胞介素-17 和白细胞介素-23 在多发性肌炎和皮肌炎患者中的作用。
Scand J Rheumatol. 2011 May;40(3):217-20. doi: 10.3109/03009742.2010.517215. Epub 2011 Jan 13.
10
Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years?特发性炎症性肌病相关的间质性肺病:过去 35 年取得了哪些进展?
Chest. 2010 Dec;138(6):1464-74. doi: 10.1378/chest.10-0180.